2026-04-05T16:31:18Z https://www.peertechzpublications.org/oai-pmh

oai:www.peertechzpublications.org:10.17352/ahcrr.000022 2020-05-01 PTZ.AHCRR:VOL5

CD103 Expression on Blastic Plasmacytoid Dendritic Cell Neoplasms in Peripheral Blood and Bone Marrow Samples Ron Lee Sally UlleryRon Thomason<p>Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) is an aggressive neoplasm which is typically CD4+, CD56+, and CD123+. There is limited information regarding CD103 expression on blastic plasmacytoid dendritic cell neoplasms. We identified six cases of BPDCN and all six had at least partial CD103 expression (31-92% positive) with the majority having significant expression of CD103. </p> Archives of Hematology Case Reports and Reviews - Peertechz Publications 2020-05-01 Case Report https://doi.org/10.17352/ahcrr.000022 en Copyright © Ron Lee et al.